Liang Chen

Years Active: 2020-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Liu, Wan Xiang, Zhizhuang Chen, Gang Wang, Rui Cao, Fenfang Zhou, Zhe Meng, Yongwen Luo, Liang Chen
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation. Cell death & disease 14 (11) (2023)
Hua Yu, Liang Chen, Xia Wang, Feng Tang, Ziyu Wan, Hao Wang, Qiqi Fu, Zhizhuang Chen, Jiageng Shi, Xuan Hu, Yisha Zuhaer, Madanyeti Aersi, Tao Liu, Huangheng Tao, Jianping Peng
STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc. Cancers 14 (23) (2022)
Hua Yu, Liang Chen, Xia Wang, Feng Tang, Ziyu Wan, Hao Wang, Qiqi Fu, Zhizhuang Chen, Jiageng Shi, Xuan Hu, Yisha Zuhaer, Madanyeti Aersi, Tao Liu, Huangheng Tao, Jianping Peng
STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc. Cancers 14 (23) (2022)
Hua Yu, Liang Chen, Xia Wang, Feng Tang, Ziyu Wan, Hao Wang, Qiqi Fu, Zhizhuang Chen, Jiageng Shi, Xuan Hu, Yisha Zuhaer, Madanyeti Aersi, Tao Liu, Huangheng Tao, Jianping Peng
STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc. Cancers 14 (23) (2022)
Yejinpeng Wang, Liang Chen, Mengxue Yu, Yayun Fang, Kaiyu Qian, Gang Wang, Lin-Gao Ju, Yu Xiao, Xing-Huan Wang
Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer. Cancer medicine 9 (20) (2020)

Liang Chen.css-eqlu8i{font-size:small;padding-left:4px;}